DNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma.

Repare Therapeutics Inc.’s RPTX share price has surged by 5.60%, which has investors questioning if this is right time to ...

Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

Malaria remains a serious global threat, requiring early detection, accurate diagnosis, mosquito control, and protective ...

A new software algorithm developed at Caltech enables researchers to easily search for viruses in RNA sequence data, enabling ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its ultra-sensitive ...

The RNA cloud formed around genes regulates their readout into RNA. Triplexes help define where in the genome a cloud forms. Proteins and other fl ...

As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, ...

Recent findings link DNA methylation entropy to chronological age, offering insights into epigenetic changes that could ...